Janssen's Biljana Naumovic talks to BioPharmaDispatch about the importance of political will in driving reform of Australia's reimbursement decision-making.
Ms Naumovic has been in Australia for almost one year and says she has been struck by the capability of the organisation she now leads, the country's economy, its resilience during the pandemic and the quality of medical research. However, she also says 'something is not quite right' and that there is a need for change in decision-making.
Timeline
3:00 - 7:00 - The 'pain points' for Australian patients and the need to focus on common themes.
7:00 - 10:50 - Setting clear goals about access to new technologies and just start.
10:50 - 14:00 - Needing the political will to drive change.
14:00 - 18:30 - Comparator choice is a serious problem that is disabling innovation.
18:30 - 26:00 - The priorities for the new health minister.
26:00 - 30:00 - If the pandemic has taught us anything, it is the link between investing in health and the economy.
30:00 - 32:40 - What should we be talking about at the end of 2022.
